CLINICAL_TRIALS
trial_result
· 2010-02-15
Clinical Trial Update: A Trial of Hydroxyurea in Spinal Muscular Atrophy [Phase 2, Phase 3]
Summary
Phase 2/Phase 3 trial evaluating hydroxyurea in spinal muscular atrophy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: Spinal Muscular Atrophy | Phase 2, Phase 3 | Status: COMPLETED